A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines: Clinical dermatology

Clinical and Experimental Dermatology

Volumn 35, Issue 5, 2010, Pages 473-476

  Katoulis, A C ^a   Alevizou, A ^a   Bozi, E ^a   Makris, M ^a   Zafeiraki, A ^a   Mantas, N ^a   Kousta, F ^a   Mistidou, M ^a   Kanelleas, A ^a   Stavrianeas, N G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEPIGMENTING AGENT; UNCLASSIFIED DRUG; UNDECYLENOYL PHENYLALANINE;

ADULT; AGED; APPLICATION SITE BURNING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; MALE; PATIENT ASSESSMENT; PATIENT SATISFACTION; PIGMENT DISORDER; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; SOLAR LENTIGINES; TOPICAL TREATMENT; TREATMENT RESPONSE;

AGED; ALPHA-MSH; CHI-SQUARE DISTRIBUTION; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENTIGO; MALE; MIDDLE AGED; PHENYLALANINE; SUNLIGHT; TREATMENT OUTCOME;

EID: 77953337385     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03605.x     Document Type: Article

References (19)

1. Ortonne JP, Pandya A, Lui H, Hexsel D. Treatment of solar lentigines. J Am Acad Dermatol 2006 54 (Suppl. 2 S262 71.
2. Ortonne JP. Pigmentary changes of the ageing skin. Br J Dermatol 1990 122 (Suppl. 37 21 8.
3. Bastiaens M, Hoefnagel J, Westendorp R et al. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Res 2004 17 : 225 229.
4. Brewster B. Delivering actives at the SCC Technology Showcase. Cosmet Toiletries 2004 119 : 18 21.
5. Schaffer JV, Bolognia JV. The melanocortin-1 receptor. red hair and beyond. Arch Dermatol 2001 134 : 1477 1485.
6. Gaggioli C, Busca R, Abbe P et al. Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes. Pigment Cell Res 2003 16 : 374 382.
7. Fuse N, Yasumoto K, Suzuki H et al. Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun 1996 219 : 702 707.
8. Orlow SJ, Hotchkiss S, Pawelek JM. Internal binding sites for MSH. Analyses in wild-type and variant Cloudman melanoma cells. J Cell Physiol 1990 142 : 129 136.
9. Chakraborty AK, Orlow SJ, Bolognia JL, Pawelek JM. Structural/functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J Cell Physiol 1991 147 : 1 6.
10. Abdel-Malek Z, Swope VB, Suzuki I et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 1995 92 : 1789 1793.
11. Pey AL, Martinez A, Charubala R et al. Specific interaction of the diastereomers 7(R)- and 7(S)-tetrahydrobiopterin with phenylalanine hydroxylase: implications for understanding primapterinuria and vitiligo. FASEB J 2006 20 : 2130 2132.
12. Snell RS. Hormonal control of pigmentation in man and other mammals. In : Advances of the Biology of Skin (Montagna W, ed.), Vol. 8. The pigmentary system.
13. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004 84 : 1155 1228.
14. Palumbo A, d'Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melaninogenesis by hydroquinone. Biochim Biophys Acta 1991 1079 : 85 90.
15. Romero C, Aberdam F, Larnier C, Ortonne JP. Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. J Cell Sci 1994 107 : 1095 1103.
16. Fleischer AB Jr., Schwartzel EH, Colby SI et al. The combination of 2% mequinol and 0, 01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. J Am Acad Dermatol 2000 42 : 459 467.
17. Weinstein GD, Nigra TP, Pochi PE et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol 1991 127 : 659 665.
18. Kang S, Goldfarb MT, Weiss JS et al. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomised trial. J Am Acad Dermatol 2003 49 : 83 90.
19. Phillips TJ, Gottlieb AB, Leyden TJ et al. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month, multicenter, randomised trial. Arch Dermatol 2002 138 : 1486 1489.